TNF and rheumatoid arthritis: Similarly, Curtis et al. reported a 2-fold increased risk for HZ in RA patients treated with tofacitinib compared to RA patients using biologics (including, but not exclusively, tumor necrosis factor α inhibitor [TNF-αi] drugs) in a real-world study [22].